Examining Off-Label Prescribing of Ozempic for Weight-Loss
Bibliographic record
Abstract
Ozempic (semaglutide) is a US Food and Drug Administration (FDA) approved medication for the treatment of type 2 diabetes and more recently has been utilized in the management of chronic weight management in some patients. It belongs to a broader class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists which help to lower the blood sugar levels of individuals with type 2 diabetes. There has been growing recent interest, especially on social media platforms such as Tik Tok, about the use of Ozempic for weight loss. While Ozempic has shown promising results in clinical trials for weight loss, there are several potential risks and concerns associated with its use. There is a lack of adequate long-term safety data on its use specifically for weight loss. Growing concerns around Ozempic include its potential misuse without proper medical supervision or its prescription off-label for weight loss leading to prescription shortages. Both of these are pressing concerns surrounding the use of this medication without medical need and ultimately resulting in risky and unnecessary medical interventions. Further study is needed in order to assess and communicate the long-term effects of Ozempic for weight loss, and health policy changes to ensure safe access.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.010 | 0.069 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.002 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.002 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.014 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".